Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-22

Clinical Trial Update: Mesenchymal Stem Cells Treat Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of mesenchymal stem cells for liver cirrhosis is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Yufang Shi | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: SUSPENDED